
### [NCIT:C35180](http://purl.obolibrary.org/obo/NCIT_C35180)
**Label:** Digestive System Carcinoma In Situ

**Subclasses:** [NCIT:C4439](http://purl.obolibrary.org/obo/NCIT_C4439) (Stage 0 Gallbladder Cancer AJCC v6 and v7), [NCIT:C134118](http://purl.obolibrary.org/obo/NCIT_C134118) (Stage 0 Appendix Carcinoma AJCC v8), [NCIT:C7788](http://purl.obolibrary.org/obo/NCIT_C7788) (Stage 0 Gastric Cancer AJCC v6 and v7), [NCIT:C8932](http://purl.obolibrary.org/obo/NCIT_C8932) (Stage 0 Colorectal Cancer AJCC v6 and v7), [NCIT:C4853](http://purl.obolibrary.org/obo/NCIT_C4853) (Stage 0 Rectal Cancer AJCC v6 and v7), [NCIT:C134271](http://purl.obolibrary.org/obo/NCIT_C134271) (Stage 0 Colon Cancer AJCC v8), [NCIT:C4593](http://purl.obolibrary.org/obo/NCIT_C4593) (Stage 0 Appendix Carcinoma AJCC v7), [NCIT:C5023](http://purl.obolibrary.org/obo/NCIT_C5023) (Stage 0 Esophageal Squamous Cell Carcinoma AJCC v7), [NCIT:C4594](http://purl.obolibrary.org/obo/NCIT_C4594) (Cecum Carcinoma In Situ), [NCIT:C4892](http://purl.obolibrary.org/obo/NCIT_C4892) (Stage 0 Small Intestinal Cancer AJCC v7), [NCIT:C134291](http://purl.obolibrary.org/obo/NCIT_C134291) (Stage 0 Rectal Cancer AJCC v8), [NCIT:C4430](http://purl.obolibrary.org/obo/NCIT_C4430) (Gastric Body Carcinoma In Situ AJCC v6 and v7), [NCIT:C4431](http://purl.obolibrary.org/obo/NCIT_C4431) (Gastric Pylorus Carcinoma In Situ AJCC v6 and v7), [NCIT:C134914](http://purl.obolibrary.org/obo/NCIT_C134914) (Stage 0 Pancreatic Cancer AJCC v8), [NCIT:C89771](http://purl.obolibrary.org/obo/NCIT_C89771) (Stage 0 Esophageal Cancer AJCC v7), [NCIT:C5729](http://purl.obolibrary.org/obo/NCIT_C5729) (Stage 0 Pancreatic Cancer AJCC v6 and v7), [NCIT:C8629](http://purl.obolibrary.org/obo/NCIT_C8629) (Stage 0 Esophageal Adenocarcinoma AJCC v7), [NCIT:C133894](http://purl.obolibrary.org/obo/NCIT_C133894) (Stage 0 Small Intestinal Adenocarcinoma AJCC v8), [NCIT:C133795](http://purl.obolibrary.org/obo/NCIT_C133795) (Stage 0 Anal Cancer AJCC v8), [NCIT:C134663](http://purl.obolibrary.org/obo/NCIT_C134663) (Stage 0 Gallbladder Cancer AJCC v8), [NCIT:C134865](http://purl.obolibrary.org/obo/NCIT_C134865) (Stage 0 Ampulla of Vater Cancer AJCC v8), [NCIT:C4444](http://purl.obolibrary.org/obo/NCIT_C4444) (Stage 0 Ampulla of Vater Cancer AJCC v7), [NCIT:C5017](http://purl.obolibrary.org/obo/NCIT_C5017) (Stage 0 Rectosigmoid Cancer AJCC v6 and v7), [NCIT:C134182](http://purl.obolibrary.org/obo/NCIT_C134182) (Stage 0 Colorectal Cancer AJCC v8), [NCIT:C7794](http://purl.obolibrary.org/obo/NCIT_C7794) (Stage 0 Anal Canal Cancer AJCC v6 and v7), [NCIT:C8400](http://purl.obolibrary.org/obo/NCIT_C8400) (Gastric Antrum Carcinoma In Situ AJCC v6 and v7), [NCIT:C3638](http://purl.obolibrary.org/obo/NCIT_C3638) (Stage 0 Colon Cancer AJCC v6 and v7), [NCIT:C3637](http://purl.obolibrary.org/obo/NCIT_C3637) (Stage 0 Esophageal Cancer AJCC v6), 

**Class expressions from DL-Learner:**

- Thing 53.20%
- [NCIT:C28079](http://purl.obolibrary.org/obo/NCIT_C28079) (Grade 3) 53.12%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) 38.48%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40114](http://purl.obolibrary.org/obo/NCIT_C40114) (Fallopian Tube Serous Cystadenofibroma))) 38.48%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40112](http://purl.obolibrary.org/obo/NCIT_C40112) (Fallopian Tube Papilloma))) 38.48%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40110](http://purl.obolibrary.org/obo/NCIT_C40110) (Borderline Fallopian Tube Endometrioid Tumor))) 38.48%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40108](http://purl.obolibrary.org/obo/NCIT_C40108) (Borderline Fallopian Tube Mucinous Tumor))) 38.48%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40107](http://purl.obolibrary.org/obo/NCIT_C40107) (Borderline Fallopian Tube Serous Tumor/Atypical Proliferative Serous Tumor))) 38.48%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40104](http://purl.obolibrary.org/obo/NCIT_C40104) (Fallopian Tube Transitional Cell Carcinoma))) 38.48%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40103](http://purl.obolibrary.org/obo/NCIT_C40103) (Fallopian Tube Mucinous Adenocarcinoma))) 38.48%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40093](http://purl.obolibrary.org/obo/NCIT_C40093) (Ovarian Squamous Cell Carcinoma))) 38.48%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40090](http://purl.obolibrary.org/obo/NCIT_C40090) (Ovarian Seromucinous Carcinoma))) 38.48%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40086](http://purl.obolibrary.org/obo/NCIT_C40086) (Ovarian Clear Cell Cystadenofibroma))) 38.48%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40083](http://purl.obolibrary.org/obo/NCIT_C40083) (Borderline Ovarian Clear Cell Cystadenofibroma))) 38.48%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40082](http://purl.obolibrary.org/obo/NCIT_C40082) (Borderline Ovarian Clear Cell Adenofibroma with Intraepithelial Carcinoma))) 38.48%


